Outcomes of Embryos Created From Abnormally Fertilized Oocytes

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07666243

Enrollment

Registered

2026-06-24

Start date

2026-06-01

Completion date

2027-06-01

Last updated

2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Fertilization, Infertility

Keywords

Fertility, Reproductive Medicine

Brief summary

The purpose of this study is to retrospectively analyze data from multiple clinics in a fertility network on embryos that were created from abnormally fertilized oocytes (AFO) including the rate of transfers and any clinical outcomes in order to inform providers in their decision making regarding AFOs.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Underwent in vitro fertilization which resulted in a blastocyst derived from an abnormally fertilized embryo

Design outcomes

Primary

Measure	Time frame	Description
Clinical Outcomes	From embryo transfer to delivery	For blastocysts derived from AFOs that were transferred, clinical outcomes include implantation rate, ongoing pregnancy rate, live birth rate, and spontaneous abortion rate.

Contacts

CONTACTLaurel Anderson, BS

landerson@inceptionllc.com3463621476

Outcome results